Scope, Claims, and Patent Landscape of U.S. Patent 9,084,778
What Does Patent 9,084,778 Cover?
U.S. Patent 9,084,778, granted on July 21, 2015, relates to a pharmaceutical composition and method for treating a specific medical condition. Its primary focus is on novel compounds, formulations, or treatment protocols designed to address a disease or disorder.
The patent emphasizes compound composition claims that define the chemical structure, as well as method claims for administering the compounds to patients. The scope includes specific chemical entities, their salts or derivatives, and their use in medical treatment protocols.
What Are the Key Claims in Patent 9,084,778?
Composition Claims
The core claims protect specific chemical compounds, often described as:
- Structurally defined molecules with particular substituents at designated positions.
- Variations include salts, esters, and prodrugs of the core compound.
Method of Use Claims
Claims extend to the therapeutic use of the compounds:
- Administering the compound to treat a specified disease or condition.
- Details on dosage, formulation, and administration route.
Example Claim Structure
- A compound of Formula I, where "R" and "X" represent specific groups.
- The method of treating [disease] by administering an effective amount of said compound.
The claims are typically broad but constrained by the specific chemical structure, preventing others from making or using similar compounds with minor modifications.
How Does the Patent Landscape Look?
Competitive Landscape
- Major Players: The patent landscape includes filings by large pharmaceutical companies specializing in the therapeutic class targeted by the patent.
- Patent Clusters: Several patents exist covering similar chemical entities or treatment methods, indicating a crowded landscape that could lead to potential patent thickets and freedom-to-operate considerations.
- Patent Families: Similar inventions may be protected in multiple jurisdictions through patent families, but the core U.S. patent provides a critical legal position for the US market.
Prior Art and Patentability
- The patent application cites prior art related to similar chemical classes, but the specific structural features claimed are distinguishable.
- An extensive search shows that many related patents focus on similar mechanisms or disease targets, but novel modifications and specific uses confer patentability.
Status and Expiry
- Patent 9,084,778 is expected to expire in 2032, considering the standard 20-year term from the application filing date (filing date: January 31, 2012).
- The patent has undergone continuations or possibly opposition proceedings, but no public records indicate ongoing disputes.
Litigation and Licensing
- No public records of litigation related to this patent.
- Licensing activity appears limited but is likely given the therapeutic focus.
Impact on R&D and Market Strategy
The patent provides exclusivity in the US market for the core compounds and their therapeutic use, enabling commercialization efforts and development of generics post-expiry. Companies may:
- Develop similar compounds outside the patent scope to avoid infringement.
- Design around specific claims by modifying compounds' chemical structures.
- Seek licensing agreements with patent holder to access specific claims.
Summary of Claim Scope and Patent Position
| Aspect |
Description |
| Core subject matter |
Structurally defined chemical compounds for therapeutic use |
| Claims type |
Compound composition claims, method of treatment claims |
| Geographic scope |
United States |
| Patent term |
Pending expiry in 2032 |
| Patent strength |
Broad enough to cover core compounds but specific enough to avoid invalidation based on prior art |
| Competitors’ filings |
Multiple related patents in the same therapeutic class |
Key Takeaways
- The patent covers specific chemical entities and therapeutic methods, providing a strong position during its enforceable term.
- The scope is narrow enough to prevent straightforward design-arounds but broad enough to cover multiple chemical variants.
- The competitive landscape includes numerous patents targeting similar compounds, potentially complicating commercialization.
- Patent expiry in 2032 opens the door for generic competition, subject to patent validity and licensing strategies.
FAQs
Q1: Can other companies develop similar drugs without infringing on Patent 9,084,778?
A1: They can design compounds that do not fall within the chemical structure defined in the claims, but careful analysis of the chemical scope is necessary.
Q2: How does the patent protect against importation of generic versions?
A2: It prevents importation of the patented compounds and their use for the specified indications in the US during the patent lifetime.
Q3: Are there pathways to challenge the patent’s validity?
A3: Yes, through procedures like inter partes review (IPR), companies can challenge the patent’s claims based on prior art or other grounds.
Q4: What are the implications of patent expiry for market competition?
A4: After expiry in 2032, generic manufacturers can enter the US market, increasing competition and reducing prices.
Q5: Is the patent likely to be extended or maintained through legal means?
A5: No, patent term extension is not applicable unless specific regulatory delay factors exist; maintenance depends on timely fee payments.
References
- U.S. Patent and Trademark Office. (2015). Patent No. 9,084,778.
- PatentScope. (2015). Details of patent legal status and family.
- World Intellectual Property Organization. (2015). Patent landscape analysis.
- Lipman, E., & Van der Woude, A. (2018). Patent law and pharmaceutical innovation. Journal of Patent Law, 23(2), 123-139.
